AI-generated summary
This review describes photobiomodulation, which uses red and near-infrared light, and its mechanisms such as mitochondrial stimulation, cytokine regulation and growth factor induction. The authors report that clinical evidence supports its use for oral mucositis, temporomandibular disorders, periodontitis, endodontic pain, implant stability and orthodontic outcomes. The abstract does not report sample sizes or the strength of the evidence behind these findings.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract does not state the number of included studies, the certainty of the evidence, or any quality assessment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Photobiomodulation (PBM), formerly known as low-level laser therapy (LLLT), utilizes red and near-infrared light to activate mitochondrial chromophores, thereby enhancing cellular activity, modulating inflammation and promoting tissue repair. Therefore, it is of interest to the mechanistic pathways of PBM, including mitochondrial stimulation, cytokine regulation and growth factor induction. Clinical evidence supports its efficacy in managing oral mucositis, temporomandibular disorders, periodontitis, postoperative endodontic pain, implant stability and orthodontic treatment outcomes.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Oral mucositis, Near-infrared, Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.